Our team focuses on mid- and late-stage collaborations with established pharmaceutical companies to accelerate breakthrough innovations that address unmet medical needs and deliver real value across key therapeutic areas.
We are highly active in acquiring assets and companies, as well as forming strategic collaborations, licensing agreements, profit-sharing models, and commercial partnerships.
Ozone’s core principle is clear — to provide access to medicine for all people, with costs optimized according to each region’s needs and circumstances.
Ozone continues to expand its supply facilities. Despite already having a strong network of pharmacies, drugstores, and contracted sub-distributors, Ozone remains committed to ensuring fair and comprehensive market distribution for all partners.
Ozone’s strategy focuses on covering all high-demand medicines while introducing unique products that are not yet available in the market.